[AWIC] |
Allison, A. (1990). Syntex
Adjuvant Formulation (SAF) as an alternative to Freund's Complete Adjuvant (FCA).
In: Adjuvants: Advances in Technology and Alternatives to Freund's (Conference
Proceedings). The Animal Resources Centre and the Faculty of Graduate Studies and
Research, McGill University: Montreal, Quebec, pp. 19-22. Allison, A.C. (1979). Mode of
action of immunological adjuvants. Journal of the Reticuloendothelial Society
26:619-630, ISSN:0033-6890. Allison, A.C. and N.E. Byars (1992). Syntex
adjuvant formulation. Research in Immunology 143(5):519-525,
ISSN:0923-2494. Allison, A.C. and N.E. Byars (1991). Immunological
adjuvants desirable properties and side-effects. Molecular Immunology
28(3):279-284, ISSN:0161-5890. ANZCCART The impact of adjuvants
(March 1994). ANZCCART News: Australian and New Zealand Council for the Care
of Animals in Research and Teaching 7(1):9, ISSN:1039-9089. Bautista-Garfias C.R., et al. (Spring
1995). Effect of three immunostimulants on the resistance against Trichinella
spiralis infection in mice (preliminary report). Archives of Medical Research
26(1):91-93, ISSN:0188-0128. Behbehani, K., D.I. Beller, and E.R.
Unanue (April 1985). The effects of beryllium and other adjuvants on Ia expression
by macrophages. The Journal of Immunology 134(4):2047-2049,
ISSN:0022-1767. Bejan, A., M. Suciu, et al. (1995). Radioimmunoanalysis
of antibodies obtained by a liposomal adjuvant. Journal of Radioanalytical
and Nuclear Chemistry 200(6):475-482, ISSN:0236-5731. Bennet, B., I.J. Check, M.R. Olsen, and
R.L. Hunter (1992). A comparison of commercially available adjuvants for use in
research. Journal of Immunological Methods 153:31-40, ISSN:0011-1759. Bernstein, D.I., C.J. Harrison, et al.
(January 1995). Effect of imiquimod as an adjuvant for immunotherapy of genital
HSV in guinea-pigs. Vaccine 13(1):72-76, ISSN:0264-410X. Bessler, W.G. and G. Jung (1992). Synthetic
lipopeptides as novel adjuvants. Research in Immunology 143(5):519-525,
ISSN:0923-2494. Bikour, M.H., E. Cornaglia and Y. Elazhary
(1994). Comparative study of the immunostimulatory properties of different
adjuvants administered with an inactivated influenza virus vaccine and evaluation of
passive immunity in pigs. Immunology and Infectious Diseases
4(3):166-172, ISSN:0959-4957. Boersma, W.J.A., W.J.C. Bogaerts, A.T.J.
Bianchi, and E. Classen (1992). Adjuvant properties of water-in-oil emulsions,
evaluation of the experiment with Specol. Research in Immunology 143(5):
503-512, ISSN:0923-2494. Bokhout, B.A., C. Van Gaalen, and Ph.J.
Van der Heijden (1981). A selected water-in-oil emulsion: composition and
usefulness as an immunological adjuvant. Veterinary Immunology and
Immunopathology 2:491-500, ISSN:0165-2427. Bomford, R. (1980). The
comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on
the antibody response to bovine serum albumin and sheep red blood cells to Freund's
incomplete and complete adjuvants, Alhydrogel, Corynebacterium parvum, Bordetella
pertussis, Muramyl dipeptide and Saponin. Clinical Experimental
Immunology 39:426-434, ISSN:0009-9104. Brewer, J.M. and J. Alexander (May 1994). Studies
on the adjuvant activity of non-ionic surfactant vesicles: Adjuvant-driven IgG2a
production independent of MHC control. Vaccine 12(7):613-619,
ISSN:0264-410X. Brewer, J.M. and J. Alexander (April
1992). The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the
BALB/c humoral response to bovine serum albumin. Immunology
75(4):570-575, ISSN:0165-2427. Broderson, J.R. (1990). Pathology
following the usage of Freund's adjuvant. In: Adjuvants: Advances in
Technology and Alternatives to Freund's (Conference Proceedings). The Animal
Resources Centre and the Faculty of Graduate Studies and Research, McGill University:
Montreal, Quebec, pp. 7-14. Broderson, J.R. (1989). A
retrospective review of lesions associated with the use of Freund's adjuvant. Laboratory
Animal Science 39:400-405, ISSN:0023-6764. Brown, L.R., C.L. Wei, and R. Langer
(October 1983). In vivo and in vitro release of macromolecules from polymeric drug
delivery systems. Journal of Pharmaceutical Sciences 72(10):1181-1185,
ISSN:0022-3549. Brumeanu, T.D., H. Zaghouani, et al.
(April 1, 1995). Derivatization with monomethoxypolyethylene glycol of Igs
expressing viral epitopes obviates adjuvant requirements. Journal of Immunology
154(7):3088-3095, ISSN:0022-1767. Buiting, A.M.J., N. van Roojen, and E.
Claassen (1992). Liposomes as antigen carriers and adjuvants in vivo. Research
in Immunology 143(5):541-548, ISSN:0923-2494. Burke, R.L., C. Goldbeck, et al. (November
1994). The influence of adjuvant on the therapeutic efficacy of a recombinant
genital herpes vaccine. Journal of Infectious Diseases 170(5):1110-1119,
ISSN:0022-1899. Byars, N.E., G. Nakano, et al. (1991). Improvement
of hepatitis B vaccine by the use of a new adjuvant. Vaccine 9(5):309-318,
ISSN:0264-410X. Cabrera-Contreras, R., Plescia, O.,
Solotorovsky, M. and M. Lynn (June 1985). Enhancement of immunogenic activity of
ribosomal preparations from Haemophilus influenzae by various
adjuvants. Vaccine 3:103-108, ISSN:0264-410X. Campbell, J.B. and Y.A. Peerbaye (1992). Saponin
Research in Immunology 143(5):526-530, ISSN:0923-2494. Cantrell, J.L.(1990). Immunological
adjuvants for bioengineered antigens. In: Adjuvants: Advances in Technology
and Alternatives to Freund's (Conference Proceedings). The Animal Resources Centre
and the Faculty of Graduate Studies and Research, McGill University: Montreal, Quebec, pp.
23-34. Carayanniotis, G. and B.H. Barber (1987). Adjuvant-free
IgG responses induced with antigens coupled to antibodies against class II MH. Nature
327:59-61, ISSN:0028-0836. Carlson, J.R. and G.A. Van Nest (1995). Comparison
of local and systemic cytokine profiles in mice after vaccination with advanced adjuvants.
Journal of Cellular Biochemistry Supplement 21A:114, ISSN:0733-1959. Carter, K.K. (1990). Nitrocellulose.
In: Adjuvants: Advances in Technology and Alternatives to Freund's (Conference
Proceedings). The Animal Resources Centre and the Faculty of Graduate Studies and
Research, McGill University: Montreal, Quebec, pp. 63-66. Cavaillon, J.M., C. Leclerc C, and J.E.
Alouf (February 15, 1983). Polyclonal antibody forming cell activation and
immunomodulation of the in vitro immune response induced by streptococcal extracellular
products. Cellular Immunology 76(1):200-206, ISSN:0008-8749. Cernescu C.E. (1994). AIDS
vaccines and adjuvant formulations. International Journal of
Immunopharmacology 16(5-6):369-379, ISSN:0192-0561. Chapel, H.M. and P.J. August (June 1976). Report
of nine cases of accidental injury to man with Freund's complete adjuvant. Clinical
and Experimental Immunology 24(3):538-541, ISSN:0009-9104. Chu, C.T., T.D. Oury, et al. (February 15,
1994). Adjuvant-free in vivo targeting. Antigen delivery by alpha 2-macroglobulin
enhances antibody formation. Journal of Immunology 152(4):538-545,
ISSN:0022-1767. Claassen, E., W. de Leeuw, P. de Greeve,
C. Hendriksen, and W. Boersma (1992). Characteristics and practical use of
new-generation adjuvants as an acceptable alternative to Freund's complete adjuvants.
Research in Immunology 143:475-477, ISSN:0959-4957. Claassen, E., W. de Leeuw, P. de Greeve,
C. Hendriksen, and W. Boersma (1992). Freund's complete adjuvant: An effective but
disagreeable formula. Research in Immunology 143:478-483,
ISSN:0959-4957. Claassen, I. and A. Osterhaus (1992). The
iscom structure as an immune-enhancing moiety: experience with viral systems. Research
in Immunology 143(5):531-541, ISSN:0923-2494. NAL call number: 410.9 P94 Descriptors: polyclonal antibody, golf ball, titer quantity, compare with Freund's or acylamide. Coghlan, L.G. and M. Hanausek (1990). Subcutaneous
immunization of rabbits with nitrocellulose paper strips impregnated with microgram
quantities of protein. Journal of Immunological Methods 129:135-138,
ISSN:0011-1759. Cooper, P.D. (1995). Vaccine
adjuvants based on gamma inulin. Pharmaceutical Biotechnology 6:559-580,
ISSN:1078-0467. Cossarini-Dunier, M. (1985). Effect
of different adjuvants on the humoral immune response of rainbow trout. Developmental
and Comparative Immunology 9:141-146, ISSN:0145-305X. Coughlin, R.T., A. Fattom, et al. (1995). Adjuvant
activity of QS-21 for experimental E. coli 018 polysaccharide vaccines. Vaccine
13(1):17-21, ISSN:0264-410X. Davidson, E., and E. Prentice (1994). TiterMax
an adjuvant update. Vaxcel, Inc.: Norcoss, GA, 1 videocassette (18 min.), 1/2 in.
Deeb, B.J., R.F. DiGiacomo, L.L. Kunz, and
J.L. Stewart (1992). Comparison of Freund's and Ribi adjuvants for inducing
antibodies to the synthetic antigen (TG)-AL in rabbits. Journal of
Immunological Methods 152:105-113, ISSN:0011-1759. DeForge, L.E., E. Takeuchi, et al. (March
1994). Immunological priming attenuates the in vivo pathophysiological response to
lipopolysaccharide. Comparison of cytokine production, tissue injury, and lethality in
complete Freund's adjuvant-primed mice and in unprimed mice. American Journal
of Pathology 144(3):599-611, ISSN:0002-9440. Degling, L. and P. Stjarnkvist P. (1995).
Biodegradable microspheres XVIII: The adjuvant effect of polyacryl starch microparticles
with conjugated human serum albumin. Vaccine 13(7):629-636,
ISSN:0264-410X. Dempsey, P.W., M.E. Allison, et al.
(January 19,1996). C3d of complement as a molecular adjuvant: bridging innate and
acquired immunity. Science 271(5247):348-350, ISSN:0036-8075 deSouza, J.B. and J.H. Playfair (October
1995). A novel adjuvant for use with a blood-stage malaria vaccine. Vaccine
13(14):1316-1319, ISSN:0264-410X. Di Tommaso, A., G. Saletti (1996).
Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic
mutant of heat-labile enterotoxin as a mucosal adjuvant. Infection and
Immunity 64(3):974-979, ISSN:0019-9567. Douce, G., C. Turcotte, et al. (February
28, 1995). Mutants of Escherichia coli heat-labile toxin lacking
ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proceedings
of the National Academy of Sciences of the United States of America 92(5):1644-1648,
ISSN:0027-8424. Eldridge, J.H., J.K. Staas, T.R. Tice, and
R.M. Gilley (1992). Biodegradable poly(DL-lactide-co-glycolide) microspheres.
Research in Immunology 143(5):557-563, ISSN:0923-2494. Erhard M., J. Kellner, R. Kuhlmann and U.
Losch (1991). Influence of various adjuvants on the synthesis of specific
antibodies of chicken, sheep and rabbit following immunization with a hapten. Journal
of Veterinary Medicine Series 38(1):21-27, ISSN:0931-184X. Ermeling, B.L., E.K. Steffen, R.E. Fish,
and R.R. Hook, Jr. (April 1992). Evaluation of subcutaneous chambers as an
alternative to conventional methods of antibody production in chickens. Laboratory
Animal Science 42(4):402-407, ISSN:0023-6764. Espuna, E., P. Riera, et al. (1994).
Activity of a non-oily adjuvant used as diluent of a lyophilized live against Aujeszky's
disease. Medicina Veterinaria 11(6):359-372, ISSN:0212-8292. European Concerted Action On Macaque
Models For Aids Research (1995). Protection of macaques against simian
immunodeficiency virus infection with inactivated vaccines: Comparison of adjuvants, doses
and challenge, viruses. Vaccine 13(3):295-300, ISSN:0264-410X. Ewasyshyn, M., B. Caplan, A-M. Bonneau,
and M. Klein (1990). Comparison of the immunopotentiating effects of different
adjuvants on the immunogenecity of a parainfluenza virus type 3 subunit vaccine.
In: Adjuvants: Advances in Technology and Alternatives to Freund's (Conference
Proceedings). The Animal Resources Centre and the Faculty of Graduate Studies and
Research, McGill University: Montreal, Quebec, pp. 35-42. Fattom, A., X. Li, et al. (October 1995). Effect
of conjugation methodology, carrier protein, and adjuvants on the immune response to
Staphylococcus aureus capsular polysaccharides. Vaccine
13(14):1288-1293, ISSN:0264-410X. Ferber, P.C., F.R. Homberger, P. Ossent,
and R.W. Fischer (1997) Generation of monoclonal antibodies: Influence of the
adjuvants on the immune response and the distress of the animals. [Herstellung
monoklonaler antikoerper: Einfluss der adjuvanttien auf die immunantwort und die belastung
der versuchstiere.] In: Ersatz- und Ergaensungsmethoden zu Tierversuchen Band
iV, Forschung ohne Tierversuche 1996, H. Schöffl, H. Spielmann, and H.A. Tritthart
(eds.), Springer-Verlag: Wein, New York, pp.269-274. Freitas, T.V., C.L. Fortes-Diaz, C.R.
Diniz, D.T. Velarde, and C.F. Freitas (1991). Immunization of horses with Crotalus
durissus terrificus (South American rattlesnake) venom. A comparison of four
different procedures. Brazilian Journal of Medical and Biological Research
24(3):281-290, ISSN: 0100-879X. Freund, J., J. Casals, and E.P. Hismer
(1937). Sensitization and antibody formation after injection of tubercle bacilli
and paraffin oil. Proceedings of the Society of Experimental Biology and
Medicine 37:509-513, ISSN:0037-9727. Gengoux, C. and C. Leclerc (January 1995).
In vivo induction of CD4+ T cell responses by antigens covalently linked to synthetic
microspheres does not require adjuvant. International Immunology
7(1):45-53, ISSN:0953-8178. Gillette, R.W. (May 4, 1987). Alternatives
to pristane priming for ascitic fluid and monoclonal antibody production. Journal
of Immunological Methods 99(1):21-23, ISSN:0022-1759. Giordano, J. and L.V. Rogers (1989). Peripherally
administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in
rats. European Journal of Pharmacology 170:83-86, ISSN:0014-2999. Glaser, V. (June 1,1995). Adjuvants
boost safety, efficacy while lowering the costs of new vaccines. Genetic
Engineering News 15(11):6-7, ISSN:0270-6377. Gonzalez, A., N.D. Greene, and B.D. Murphy
(1991). Active immunization against GnRH in mice and rats: Adjuvant B, an
alternative to Freund's adjuvant. Journal of Animal Science 69 (Suppl.
1):396, ISSN:0021-8812. Goodman, M.G. (1995). A new
approach to vaccine adjuvants. Immunopotentiation by intracellular T-helper-like signals
transmitted by loxoribine. Pharmaceutical Biotechnology 6:581-609,
ISSN:1078-0467. Gray, G., R. McGhie, and J.A. Love
(October/December 1992). Antibody production in rabbits: Reducing animal numbers.
Canadian Association for Laboratory Animal Science Newsletter 26(4/5):106-110,
ISSN: 0045-4354 Grubhofer, N. (January 1995). An
adjuvant formulation based on N-acetylglucosaminyl-N-acetylmuramyl-L-alanyl-D-isoglutamine
with, dimethyldioctadecylammonium chloride and zinc-L-proline complex as synergists.
Immunology Letters 44(1):19-24, ISSN:0165-2478. Gupta, R.K., Jr. P. Griffin, et al.
(1996). The role of adjuvants and delivery systems in modulation of immune
response to vaccines. Advances in Experimental Medicine and Biology
397:105-113, ISSN:0065-2598. Gupta, R.K., B.E. Rost, E. Relyveld, and
G.R. Siber (1995). Adjuvant properties of aluminum and calcium compounds.
Pharmaceutical Biotechnology 6:229-248, ISSN:1078-0467. Gupta, R.K. and G.R. Siber (October 1995).
Adjuvants for human vaccines: Current status, problems and future prospects.
Vaccine 13(14):1263-1276, ISSN:0264-410X. Gupta, R.K. and G.R. Siber (March 1994). Comparison
of adjuvant activities of aluminum phosphate, calcium phosphate and stearyl tyrosine for
tetanus toxoid. Biologicals 22(1):53-63, ISSN:1045-1056. Gursel, M. and G. Gregoriadis (1995). Immunoadjuvant action of liposomes containing interleukin-2 as a co-adjuvant. Proceedings of the Controlled Release Society 22:572-573, ISSN:1022-0178. Descriptors: mice, intramuscular drug administration, interleukin 2, liposome, immunoglobulin G.Gustafson, G.L. and M.J. Rhodes (1992). Bacterial
cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that
enhance protective immunity. Research in Immunology 143(5):483-488,
ISSN:0923-2494. Hanly, W.C. (January 1995). Freund's
adjuvant and alternatives. BRL Bulletin 10(1):1-4. Hanly, W. C. (January 1995). UIC
guidelines for the use of adjuvants in animals. BRL Bulletin 10(1):1-4. Hanly, W.C. (September 1994). Adjuvants
and their use. Part II. BRL Bulletin 9(9):1-4. Hanly, W.C. (August 1994). Adjuvants
and their use. Part I. BRL Bulletin 9(8):1-4. Hariharan, K., and G. Braslawsky et al.
(1995). The induction of cytotoxic T cells and tumor regression by soluble
antigens in adjuvant formulation. Eighty-sixth Annual Meeting of the American
Association for Cancer Research, Toronto, Ontario, Canada, March 18-22, 1995. Proceedings
of the American Association for Cancer Research Annual Meeting 36:491,
ISSN:0197-016X. NAL call number: 448.3 IM6 Descriptors: mouse, water-in-oil emulsion, ovalbumin, mechanisms, titer. Hess, H., M.K. Gately, et al. (1996). High
doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized
with type II collagen in complete Freund's adjuvant. European Journal of
Immunology 26(1):187-191, ISSN:0014-2980. Hibma, M. and J.F. Griffin (March 1992). The
effect of adjuvants on active and passive immunity in pregnant deer and their offspring.
Veterinary Immunology and Immunopathology 31(3-4): 279-287, ISSN: 0165-2427. Hilgers, L.A., P.L. Platenburg, et al.
(May 1994). A novel non-mineral oil-based adjuvant. II. Efficacy of a synthetic
sulfolipopolysaccharide in a squalane-in-water emulsion in pigs. Vaccine 12(7):661-665,
ISSN:0264-410X. Hilgers, L.A.T. and H. Snippe (1992). DDA
as an immunological adjuvant. Research in Immunology 143(5):494-503,
ISSN:0923-2494. Hill, S.L., M.G. Landavere, and N.R. Rose
(1996). The adjuvant effect of silicone gel and silicone elastomer particles in
rats. Current Topics in Microbiology and Immunology 210:123-137,
ISSN:0070-217X. Hillam, R.P., R.P. Tengerdy, and G.L.
Brown (September 1974). Local antibody production against the murine toxin of Yersina
pestis in a golf ball-induced granuloma. Infection and Immunity
10(1):458-463, ISSN:0019-9567. Hornung, R.L., D.L. Longo, et al. (1995). Induction
of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel
muramyl dipeptide adjuvant,
N-acetyl-D-glucosaminyl-(beta1-4)-N-acetylmuramyl-L-alanyl-Disoglutamine (GMDP). Therapeutic
Immunology 2(1):7-14, ISSN:0967-0149 Hsia, J., T. Tang, M. Parrott, and K.
Rogalla (November 1994). Augmentation of the immune response to influenza vaccine
by acetylsalicylic acid: a clinical trial in a geriatric population. Methods
and Findings in Experimental and Clinical Pharmacology 16(9):677-683, ISSN:0379-0355.
Hsieh, D.S.T., W.D. Rhine, and R. Langer
(January 1983). Zero-order controlled-release polymer matrices for micro- and
macromolecules. Journal of Pharmaceutical Sciences 72(1):17-22,
ISSN:0022-3549. Hui, G.S.N., L.Q. Tam, et al. (1991). Synthetic
low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund's complete
adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major
merozite surface protein, gp195. Infection and Immunity 59(5):1585-1591,
ISSN:0019-9567. Hunter R., M. Olsen and S. Buynitzky
(April 1991) Adjuvant activity of non-ionic block copolymers. IV. Effect of
molecular weight and formulation on titer and isotype of antibody. Vaccine
9:250-256, ISSN:0264-410X. Hunter, R.L. and B. Bennett (1984). The
adjuvant activity of non-ionic block polymer surfactants. II. Antibody formation and
inflammation related to the structure of triblock and actablock copolymers. Journal
of Immunology 133(6):3167-3175, ISSN:0022-1767. Ibsen P.H., A. Holmet al. (1992). Induction
of polyclonal antibodies to the S1 subunit of pertussis toxin by synthetic peptides
coupled to Ppd: effect of conjugation method, adjuvant, priming and animal species.
APMIS: Acta Pathologica Microbiologica et Immunologica Scandinavica 100(2):159-169,
ISSN:0903-4641. Ishihara, C., M. Miyazawa, J. Nishio, I.
Azuma, and B. Chesebro (1992). Use of low toxicity adjuvants and killed virus to
induce protective immunity against the Friend murine leukaemia retrovirus-induced disease.
Vaccine 10(5):353-356, ISSN:0264-410X. Jackson L.A. and J.P. Opdebeeck (May
1995). The effect of various adjuvants on the humoral immune response of sheep and
cattle to soluble and membrane midgut antigens of Boophilus microplus. Veterinary
Parasitology 58(1-2):129-141, ISSN:0304-4017. Jennings, V.M. (1995). Review of
selected adjuvants used in antibody production. ILAR Journal
37(3):119-125, ISSN:0018-9960. Johnson, D.K. (1994). Adjuvant
comparison in rabbits. In: Rodents and Rabbits Current Research Issues:
Proceedings of a conference sponsored by SCAW and WARDS held in Washington, DC on May 21,
1993 S.M. Niemi, J.S. Venable and H.N. Guttman, eds., Scientist Center for Animal
Welfare: Greenbelt Maryland, WARDS: Washington, DC, pp. 77-80. Johnson, D.K. (1994). Adjuvant
comparison in rabbits. Science and Animal Care 5(2):2-4. Johnston, B.A., H. Eisen, and D. Fry
(January 1991). An evaluation of several adjuvant emulsion regimens for the
production of polyclonal antisera in rabbits. Laboratory Animal Science
41(1): 15-21, ISSN:0023-6764. Jones, G.L., L. Spencer, R. Lord, H.
Edmundson and A.J. Saul (May-June 1991). High-titer antisera production using
three adjuvants and peptide conjugates derived from malarial surface antigen MSA-2.
Peptide Research 4(3):138-141, ISSN:1040-5704. Jones, G.L., L. Spencer, R. Lord, and A.J.
Saul (1996). Effect of context and adjuvant on the immunogenecity of recombinant
proteins and peptide conjugates derived from the polymorphic malarial surface antigen
MSA2. Vaccine 14(1):77-84, ISSN:0264-410X. Kato, H., M. Shibano, et al. (1994). Relationship
between hemolytic activity and adsorption capacity of aluminum hydroxide and calcium
phosphate as immunological adjuvants for biologicals. Microbiology and
Immunology 38(7):543-548, ISSN:0385-5600. Katz, D., S. Lehrer, O. Galan, B.E. Lachmi
and S. Cohen (November 1991). Adjuvant effects of dimethyl dioctadecyl ammonium
bromide, complete Freund's adjuvant and aluminium hydroxide on neutralizing antibody,
anitibody-isotope and delayed-type hypersensitivity responses to Semliki Forest virus in
mice. FEMS Microbiology Immunology 3(6):305-320, ISSN:0920-8534. Katz, D., Inbar, I., Samina, I., Peleg,
B.A., Heller, D.E. (December 1993). Comparison of dimethyl dioctadecyl ammonium
bromide, Freund's complete adjuvant and mineral oil for induction of humoral antibodies,
cellular immunity and resistance to Newcastle disease virus in chickens. FEMS
Immunology and Medical Microbiology 7(4):303-313, ISSN:0928-8244. Ke, Y., R.L. Hunter, and J.A. Kapp (1995).
Induction of humoral and cytolytic responses by ovalbumin in TiterMax and a new
synthetic copolymer adjuvant. Vaccine Research 4(1):29-45,
ISSN:1056-7909. Kellner, J., M. Erhard, I. Schranner, and
U. Lösch (January 1992). The influence of various adjuvants on antibody synthesis
following immunization with a hapten. Biological Chemistry Hoppe-Seyler
373:51-55, ISSN:0177-3593. Kim, C.K. and E.J. Jeong (1995). Development
of dried liposome as effective immuno-adjuvant for hepatitis B surface antigen. International
Journal of Pharmaceutics 115(2):193-199, ISSN:0378-5173. Kleinau, S., H. Erlandsson, R. Holmdahl,
L. Klareskog (December 1991). Adjuvant oils induce arthritis in the DA rat. I.
Characterization of the disease and evidence for an immunological involvement. Journal
of Autoimmunology 4(6):871-880, ISSN:0896-8411. Kleinman, N.R., A.B. Kier, E. Diaconu and
J.H. Lass (August 1993). Posterior paresis induced by Freund's adjuvant in guinea
pigs. Laboratory Animal Science 43(4):364-366, ISSN:0023-6764. Krzystyniak, K., E. Kozlowska, et al.
(1995). Different T-cell activation by streptozotocin and Freund's adjuvant in
popliteal lymph node (PLN.). International Journal of Immunopharmacology
17(3):189-196, ISSN:0192-0561. Lachman, L.B., L. Shih, et al. (1995). Cytokine-containing
liposomes as adjuvants for HIV subunit vaccines. AIDS Research and Human
Retroviruses 11(8):921-932, ISSN:0889-2229. Lacour, F. (1985). Polyadenylic-polyuridylic
acid: biological response modifying activities in mice. In vivo organ
distribution and pharmacokinetics in rabbits. Journal of Biological Response
Modifiers 4:490-494, ISSN:0732-6580. Lacy, M.J. and E.W. Voss, Jr. (1986). A
modified method to induce immune polyclonal ascites fluid in BALB/c mice using Sp2/0-Ag14
cells. Journal of Immunological Methods 87:169-177, ISSN:0022-1759. Langer, R. (1981). Polymers for
the sustained release of macromolecules: Their use in a single-step method of
immunization. Methods in Enzymology 73:57-75, ISSN:0076-6879. Langer, R., L. Brown, and E. Edelman
(1985). Controlled release and magnetically modulated release systems for
macromolecules. Methods in Enzymology 112:399-423, ISSN:0076-6879. Langhein, C. and J.F. Newman (November
1987). Antibody response to bacterial antigens covalently bound to biodegradable
polymerized serum albumin beads. Journal Applied Bacteriology
63(5):443-448, ISSN: 0021-8847. Larson, A.A., D.R. Brown, S. El-Atrash,
and M.M. Walser (1986). Pain threshold changes in adjuvant-induced inflammation: A
possible model of chronic pain in the mouse. Pharmacology, Biochemistry and
Behavior 24:49-53, ISSN:0091-3057. Leenaars, P.P., A.M., Hendrikson, M.A.
Koedam, and E. Claassen (October 1996). Evaluation of commercially available
alternatives to Freund's Complete Adjuvant in mice. In: Second World Congress
on Alternatives and Animal Use in the Life Sciences October 20-24, 1996, Utrecht, The
Netherlands, J.B.F. van der Valk and L.F.M. van Zutphen, eds., Alternatives to
Laboratory Animals: ATLA 24(Special Issue):119, ISSN:0261-1929. Leenaars, P.P., A. M. Hendriksen, et al.
(1995). Comparison of adjuvants for immune potentiating properties and side
effects in mice. Veterinary Immunology and Immunopathology
48(1/2):123-138, ISSN:0165-2427. Leenaars, P.P., A.M., Hendrikson, A.F.
Angulo, M.A. Koedam, and E. Claassen (1994). Evaluation in rabbits of several
types of adjuvant. In: Welfare and Science Proceedings of the Fifth Symposium
of the Federation of European Laboratory Animal Science Associations, June 8-11, 1993,
Brighton, UK John Bunyan, ed., Royal Society of Medical Press: London, pp. 155-161. Leenaars, P.P., A.M., Hendrikson, A.F.
Angulo, M.A. Koedam, and E. Claasen (1994). Evaluation of several adjuvants as
alternatives to the use of Freund's adjuvant in rabbits. Veterinary
Immunology and Immunopathology 40:225-241, ISSN:0165-2427. Linblak, E.B. and J.V. Sparack (1987). Basic
concepts in the application of immunological adjuvants. Scandinavian Journal
of Laboratory Animal Science 14:1-13, ISSN:0901-3393. Lindsay, D.S., R. Parton, A.C. Wardlaw
(November 1994). Adjuvant effect of pertussis toxin on the production of
anti-ovalbumin IgE in mice and lack of direct correlation between PCA and ELISA. International
Archives of Allergy and Immunology 105(3):281-288, ISSN:1018-2438. Lipman, N.S., L.J. Trudel, J.C. Murphy,
and Y. Sahali (April 1992). Comparison of immune response potentiation and in vivo
inflammatory effects of Freund's and RIBI adjuvants in mice. Laboratory
Animal Science 42(2):193-197, ISSN:0023-6764. Lofthouse, S.A., A.E. Andrews, et al.
(August 1995). Humoral and cellular responses induced by intradermally
administered, cytokine and conventional adjuvants. Vaccine 13(12):1131-1137,
ISSN:0264-410X. Lygren, I., P.G. Burhol, and H.L. Waldum
(January-March 1984). Production and evaluation of VIP antibodies in rabbits.
Materia Medica Polona 1(51):26-29, ISSN:0025-5246. Ma, J., P.A. Bulger, et al. (August 1994).
Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity
of recombinant OspA and OspB of Borrelia burgdorferi. Vaccine
12(10):925-932, ISSN:0264-410X. Mallon, F.M., M.E. Graichen, B.R. Conway,
M.S. Landi, and H.C. Hughes (September 1991). Comparison of antibody response by
use of synthetic adjuvant system and Freund complete adjuvant in rabbits. American
Journal of Veterinary Research 52(9):1503-1506, ISSN:0002-9645. Masihi, K.N., W. Brehmer, W. Lange, E.
Ribi, S. Schwartzman (1984). Protective effect of muramyl dipeptide analogs in
combination with trehalose dimycolate against aerogenic influenza virus and Mycobacterium
tuberculosis infections in mice. Journal of Biological Response
Modifiers 3:663-671, ISSN:0732-6580. McClimon, L.B., Glick, B., Dick, J.W.
(April/June 1994). Effect of three commercially available adjuvants on the
production of antibodies to Pasteurella multocida in broilers. Avian Diseases
38(2):354-357, ISSN:0005-2086. McMurtry, J.P. and N.C. Steele (1989).
Development of an avian calcitonin radioimmunoassay using synthetic chicken calcitonin as
immunogen. Comparative Biochemistry and Physiology Part B: Comparative
Biochemistry 94(B):49-51, ISSN:0305-0491. Mears, G.J. (1995). Effect of
adjuvant on somatostatin (SRIF). antibody production in calves. Canadian
Journal of Animal Science 75(3):473-475, ISSN:0008-3984.
NAL call number: 41.8 C163
Descriptors: Freund's adjuvant,
alhydrogel, havlogen adjuvant, antibody titers, cattle, dairy industry, pharmaceuticals. Medina, E., S.R.Talay, G.S. Chhatwal, and C.A. Guzman (March 1998). Fibronectin-binding protein I of Streptococcus pyogenesis a promising adjuvant for
antigens delivered by mucosal route. European Journal of Immunology28(3):1069-1077, ISSN:0014-2980. Michelson, A.M. F. Lacour, and J. Lacour
(1985). Polyadenylic Polyuridylic Acid in the Cotreatment of Cancer. Proceedings
of the Society for Experimental Biology and Medicine 179:1-8. Miettinen, A. (July 1982). Nephritogenic
antibodies against kidney brush border glycoproteins in rabbits injected with Freund's
adjuvant. Laboratory Investigation 47(1):67-75, ISSN:0023-6837. Millet, P., K.K. Grady, et al. (April
1995). Use of the rhesus monkey as an experimental model to test the degree of
efficacy of an anti-sporozoite peptide malaria vaccine candidate combined with
copolymer-based adjuvants. American Journal of Tropical Medicine and Hygiene
52(4):328-335, ISSN:0002-9637. Mohagheghpour, N., M. Dawson, et
al.(1995). Glucans as immunological adjuvants. Advances in
Experimental Medicine and Biology 383(13-22), ISSN:0065-2598. Mordelet-Dambrine, M., G.
Stanislas-Leguern, et al.(December 1994). Respiratory epithelial permeability in
complete Freund's adjuvant rat lung granulomatosis. American Journal of
Respiratory and Critical Care Medicine 150(6 Part 1):1660-1666, ISSN:1073-449X. Mukerjee, R. and U.C. Chaturvedi (December
1995). Effect of adjuvants on immunization with dengue virus-induced cytotoxic
factor. Clinical and Experimental Immunology 102(3):496-500,
ISSN:0009-9104. Murphey-Corb, M., S. Ohkawa, et al.
(1994). Comparative efficacy of a whole killed SIV vaccine in combination with
various adjuvants. AIDS Research and Human Retroviruses 10(Suppl. 2):
S115, ISSN:0889-2229. Naim, J.O., K.M. Ippolito, and R.J.
Lanzafame (March 1995). The effect of molecular weight and gel preparation on
humoral adjuvancy of silicone oils and silicone gels. Immunological
Investigations 24(3):537-547, ISSN:0882-0139. Nakaoka, R., Y. Tabata, and Y. Ikada
(1995). Potentiality of gelatin microsphere as immunological adjuvant. Vaccine
13(7):653-661, ISSN: 0264-410X. Nakashima, S. and H. Kamikawa (1984). Accelerated
expansion of antibody heterogeneity by complete Freund's adjuvant during the response to
bacterial amylase. Immunology 53:837-845, ISSN:0019-2805. Neimi, S.M., J.G. Fox, L.R. Brown, and R.
Langer (December 1985). Evaluation of ethylene-vinyl acetate copolymer as a
non-inflammatory alternative to Freund's Complete Adjuvant in rabbits. Laboratory
Animal Science 35(6): 609-612, ISSN:0023-6764. Nellore, R.V., P.G. Pande, et al.
(September-October 1992). Evaluation of biodegradable microspheres as vaccine
adjuvant for hepatitis B surface antigen. Journal of Parenteral Science and
Technology 46(5):176-180, ISSN:0279-7976. Nicklas, W. (October 1996). Alternatives
to Freund's adjuvant. In: Second World Congress on Alternatives and Animal
Use in the Life Sciences October 20-24, 1996, Utrecht, The Netherlands, J.B.F. van
der Valk and L.F.M. van Zutphen, eds., Alternatives to Laboratory Animals: ATLA 24(Special
Issue):182, ISSN:0261-1929. Nicklas, W. (1992). Aluminum
salts. Research in Immunology 143(5):489-494, ISSN:0923-2494. Nilsson, B.O. and A. Larsson (1992). Inert
carriers for immunization. Research in Immunology 143(5):553-557,
ISSN:0923-2494. Olson, M.E. (April 1994). Vaccination
and adjuvants. Canadian Association for Laboratory Animal Science Newsletter
28(2):42-43, ISSN: 0045-4354 Osebold, J.W. (1982). Mechanisms
of action by immunologic adjuvants. Journal of the American Veterinary
Medical Association 181:983-987, ISSN:0003-1488. Ott, G., G.L. Barchfeld, et al. (November
1995). Enhancement of humoral response against human influenza vaccine with the
simple submicron oil/water emulsion adjuvant MF59. Vaccine
13(16):1557-1562, ISSN:0264-410X. Ozpolat, B, X.M. Rao, M.F. Powell, L.B. Lachman (March 20, 1998). Immunoliposomes containing antibodies to costimulatory molecules as adjuvants for HIV subunit
vaccines.
AIDS Research and Human Retroviruses 14(5):409-417, ISSN:0889-2229.
Park, S.J., W.H. Kim, et al. (June 1995). Adjuvant
effect of polyadenylic polyuridylic acid on antibody production of recombinant hepatitis B
surface antigen in mice. International Journal of Immunopharmacololgy
17(6):513-516, ISSN:0192-0561.
Parmentier, H.K., M. Walraven, and M.G Nieuwland (February 1998). Antibody responses and body weights of chicken lines selected for high and low humoral responsiveness to sheep red blood cells. 2. Effects of separate application of Freund's Compl
e
te and Incomplete Adjuvant and antigen. Poultry Science 77(2):256-265, ISSN:0032-5791.
Perdigon, G., S. Alvarez, et al. (1995). Comparative
effect of the adjuvant capacity of Lactobacillus casei and lipopolysaccharide on
the intestinal secretory antibody response and resistance to Salmonella infection in mice.
Food and Agricultural Immunology 7(3):283-294, ISSN:0954-0105. Powell, M.F., D.J. Eastman, et al.
(February 1995). Effect of adjuvants on immunogenicity of MN recombinant
glycoprotein 120 in guinea pigs. AIDS Research and Human Retroviruses
11(2):203-209, ISSN:0889-2229. Powers, D.C., P.J. Hanscome, and P.J.
Pietrobon (October 1995). In previously immunized elderly adults inactivated
influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by
liposome adjuvant. Vaccine 13(14):1330-1335, ISSN:0264-410X. Preis, I. and R.S. Langer (1979). A
single-step immunization by sustained antigen release. Journal of
Immunological Methods 28:193-197, ISSN:0022-1759. Pruett, J.H. and P. Stromberg (May 1995). Effects
of adjuvants on bovine humoral and cellular responses to hypodermin A.
Veterinary Parasitology 58(1-2):143-153, ISSN:0304-4017. Rehmani, S.F. and P.B. Spradbrow
(September 1995). The influence of adjuvants on oral vaccination of chickens
against Newcastle disease. Veterinary Microbiology 46(1-3):63-68,
ISSN:0378-1135. Rhine, W.D., D.S.T. Hsieh, and R. Langer
(1980). Polymers for sustained macromolecule release: Procedures to fabricate
reproducible delivery systems and control release kinetics. Journal of
Pharmaceutical Sciences 69(3):265-270, ISSN:0022-3549. Ribi, E. (1984). Beneficial
modification of the endotoxin molecule. Journal of Biological Response
Modifiers 3:1-9, ISSN:0732-6580. Ribi, E., J. Central, and K. Tacoma (March
1985). A new immunomodulator with potential clinical applications: Monophosphoryl
Lipid A, a detoxified endotoxin. Clinical Immunology Newsletter 6:33-36,
ISSN: 0197-1859. Richens, E.R., M.F. Tungekar, and K.
Behbehani (1987). Complete Freund's adjuvant has a differential amplification
action on the induction of diabetes by streptozotocin in various murine strains: CFA
amplifies STZ in murine diabetes. Pathology 19:351-357, ISSN:0031-3025. Roberts, M., A. Bacon, et al. (June 1995).
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity,
PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins.
Infection and Immunity 63(6):2100-2108, ISSN:0019-9567 Robuccio, J.A., J.W. Griffith, et al.
(August 1995). Comparison of the effects of five adjuvants on the antibody
response to influenza virus antigen in guinea pigs. Laboratory Animal Science
45(4):420-426, ISSN:0023-6764. Ronnberg, B., Fekadu, M. and B. Morein
(1995). Adjuvant activity of non-toxic Quillaja saponaria Molina
components for use in ISCOM matrix. Vaccine 13(14):1375-1382,
ISSN:0264-410X. Ruiloba de Leon, S., J.
Gonzalez-Y-Merchand, et al. (1989). Adjuvant activity of the capsular
polysaccharide of Klebsiella-pneumoniae K8 on the immune response to the tetanus toxoid
vaccine. Revista Latinoamericana De Microbiologia 31(4):335-340,
ISSN:0187-4640. Sah, H., R. Toddywala, and Y.W. Chien
(1995). Continuous release of proteins from biodegradable microcapsules and in
vivo evaluation of their potential as a vaccine adjuvant. Journal of
Controlled Release 35(2-3):137-144, ISSN:0168-3659. Sarkar, A.K. and M.K. Das (1984). Preparation
of anti-polysaccharide antiserum using liposomes as immunological adjuvant. Immunology
Letters 8:197-200, ISSN:0165-2478. Schultz, N., R. Oratz, et al. (April 1995)
Effect of DETOX as an adjuvant for melanoma vaccine. Vaccine 13(5):503-508,
ISSN:0264-410X. Schwarzkopf, C. and B. Thiele (October
1996). Chicken IGY: Efficacy of alternative adjuvants compared to FCA. In:
Second World Congress on Alternatives and Animal Use in the Life Sciences October
20-24, 1996, Utrecht, The Netherlands, J.B.F. van der Valk and L.F.M. van Zutphen,
eds., Alternatives to Laboratory Animals: ATLA 24(Special Issue):1120,
ISSN:0261-1929. Schwarzkopf, C. and B. Thiele (1996). Effectivity
of alternative adjuvants in comparison to Freund's complete adjuvant. Alternativen
zu Tierexperimenten: ALTEX 13 (Supplement 96):22-25, ISSN: 0946-7785. Sedlik C., R. Perraut, et al. (1996). Antigens
linked to synthetic microspheres induce immune responses in primates in the absence of
adjuvant. Immunobiology 195(1):105-118, ISSN:0171-2985. Shahin, R., M. Leef, et al. (1995). Adjuvanticity
and protective immunity elicited by Bordetella pertussis antigens encapsulated in
poly(DL-lactide-co-glycolide) microspheres. Infection and Immunity
63(4):1195-1200, ISSN:0019-9567. Shahum, E. and H.M. Therien (January
1995). Liposomal adjuvanticity: effect of encapsulation and surface-linkage on
antibody production and proliferative response. International Journal of
Immunopharmacology 17(1):9-20, ISSN:0192-0561. Shehadeh, N., F. Calcinaro, et al. (March
19, 1994). Effect of adjuvant therapy on development of diabetes in mouse and man.
Lancet (England) 343(8899):706-707, ISSN:0140-6736. Siegel, R.A. and R. Langer (1984). Controlled
release of polypeptides and other macromolecules. Pharmaceutical Research 1984:2-10.
Skea, D.L. and B.H. Barber (1992). Adjuvant-independent
induction of immune responses by antibody-mediated targeting of protein and peptide
antigens. Research in Immunology 143(5):568-572, ISSN:0923-2494. Smith R.E., A.M. Donachie, F.H. McLaren and A.M. Mowat (1998). Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional i
nterleukin-4 or interferon-gamma. Immunology 93(4):556-562, ISSN:0019-2805.
Smith, D.E., M.E. O'Brien, et al.
(December 1992). The selection of an adjuvant emulsion for polyclonal antibody
production using a low-molecular-weight antigen in rabbits. Laboratory Animal
Science 42(6):599-601, ISSN:0023-6764. Solange, A. (January 12, 1995). Potential
adjuvants for synthetic vaccines. I. Modulators of macrophage activation. Chemistry
and Physics of Lipids 75(1):51-58, ISSN:0009-3084. Soltysik, S., J.Y. Wu, et al. (1995). Structure/function
studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in
adjuvant function. Vaccine 13(15):1403-1410, ISSN:0264-410X. Srinivas, G.R., C.O. Chichester, et al.
(March 1994). Production of type II collagen specific monoclonal antibodies.
Immunological Investigations 23(2):85-98, ISSN:0882-0139. Stahl-Henning, C. and G. Rossi G., et al.
(1995). Protection of macaques against simian immunodeficiency virus infection
with inactivated vaccines: Comparison of adjuvants, doses and challenge viruses. Vaccine
13(3):295-300, ISSN:0264-410X. Steiner, J.W., B. Langer, and D.L.
Schwartz (1960). The local and systemic effects of Freund's adjuvant and its
fractions. Archives of Pathology 70:424-434. Stewart-Tull, D. (October 1996). Refinement
to the use of adjuvants in the production of polyclonal antibodies. In: Second
World Congress on Alternatives and Animal Use in the Life Sciences October 20-24, 1996,
Utrecht, The Netherlands, J.B.F. van der Valk and L.F.M. van Zutphen, eds., Alternatives
to Laboratory Animals: ATLA 24(Special Issue):118, ISSN:0261-1929. Stieneker, F., G. Kersten, et al. (January
1995). Comparison of 24 different adjuvants for inactivated HIV-2 split whole
virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the
formulations. Vaccine 13(1):45-53, ISSN:0264-410X. Stills, Jr., H.F. and M.Q. Bailey (April
1991). The use of Freund's complete adjuvant. Lab Animal
20(4):25-30, ISSN:0093-7355.
Suckow M.A. and F.A. Douglas (1997). Polyclonal antibody production.In: The Laboratory Rabbit: A Volume in the Laboratory Animal Pocket Reference Series CRC Press, Inc.: Boca Raton,
F
L, pp. 96-99, ISBN:0-8493-2561-7. Sugimoto, M., K. Ohishi, et al. (1995). Oligomannose-coated
liposomes as an adjuvant for the induction of cell-mediated immunity. FEBS
Letters 363(1-2):53-56, ISSN:0014-5793. Suzue, K. and R.A. Young (January
15,1996). Adjuvant-free hsp70 fusion protein system elicits humoral and cellular
immune responses to HIV-1 p24. Journal of Immunology 156(2):873-879,
ISSN:0022-1767. Tagliabue, A., P. Ghiara, and D. Boraschi
(1992). Non-inflammatory peptide fragments of IL1 as safe new-generation
adjuvants. Research in Immunology 143(5):563-568, ISSN:0923-2494. Tamura, S., A. Yamanaka, et al. (April
1994). Synergistic action of cholera toxin B subunit (and Escherichia coli
heat-labile toxin B subunit). and a trace amount of cholera whole toxin as an adjuvant for
nasal influenza vaccine. Vaccine 12(5):419-426, ISSN:0264-410X. Tamura, M., Y.C. Yoo, et al. (January
1995). Effects of muramyl dipeptide derivatives as adjuvants on the induction of
antibody response to recombinant hepatitis B surface antigen. Vaccine 13
(1):77-82, ISSN:0264-410X. Taylor, C.E. (September 1995). Cytokines
as adjuvants for vaccines: Antigen-specific responses differ, from polyclonal responses.
Infection and Immunity 63(9):3241-3244, ISSN:0019-9567.
Tochikubo, K., M. Isaka, Y. Yasuda, et al. (1998). Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to muc
osally co-administered bovine serum albumin. Vaccine 16(2-3):150-155, ISSN:0264-410X.
Trauger, R.J., A.E. Daigle, et al. (1995).
Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen:
results of a double-blind, adjuvant controlled trial. Journal of Acquired
Immune Deficiency Syndromes and Human Retrovirology 10(Suppl. 2):S74-S82,
ISSN:1077-9450. Turanek, J., M. Toman, et al. (February
1994). Adjuvant effect of liposomes and adamantylamide dipeptide on antigenicity
of entrapped synthetic peptide derived from HIV-1 transmembrane region glycoprotein gp41.
Immunology Letters 39(2):157-161, ISSN:0165-2478. Vaitukaitis, J.L. (1981). Production
of antisera with small doses of immunogen: Multiple intradermal injections. Methods
in Enzymology 73:47-52, ISSN:0076-6879. Verheul, A.F.M. and H. Snippe (1992). Non-ionic
block polymer surfactants as immunological adjuvants. Research in Immunology
143(5):512-519, ISSN: 0923-2494. Verma, I., P. Pancholi and G.K. Khuller
(1995). Comparative study of the adjuvanticity of FIA and phosphatidylcholine
liposomes for purified mycobacterial RNA. Journal of Liposome Research
5(2): 227-240, ISSN:0898-2104. Vogel, F.R. (1995). The role of
adjuvants in retroviral vaccines. International Journal of Immunopharmacology
17(2):85-90, ISSN:0192-0561. Vogel, F.R. and C.R. Alving (1995). Adjuvants
and novel vaccines: Conference summary. AIDS Research and Human Retroviruses
11(10):1277-1278, ISSN:0889-2229. Von Blomberg-Van der Flier, M., R.J.
Scheper, G.H. Boerrigter, L. Polak (1984). Induction of contact sensitivity to a
broad variety of allergens with haptenized macrophages. Journal of
Investigative Dermatology 83(2):91-95, ISSN:0022-202X. Wagland, B.M., S.J. McClure, et al.
(1996). Effect of Freund's adjuvants on guinea pigs infected with, or vaccinated
against, Trichostrongylus colubriformis. International Journal for
Parasitology 26(1):85-90, ISSN:0020-7519. Warren, H.S., F.R. Vogel, and L.A. Chedid
(1986). Current states of immunological adjuvants. Annual Review of
Immunology 4:369-388, ISSN:0732-0582. Westbrook, S.L., V. Bundoora, and G.H.
McDowell (1994). Immunization of lambs against somatotropin release inhibiting
factor to improve productivity: comparison of adjuvants. Australian Journal
of Agricultural Research. 45(8):1693-1700, ISSN: 0004-9409. Whittington, R.J., B.L. Munday, et al.
(1994). Humoral and peritoneal cell responses of rainbow trout (Oncorhynchus
mykiss) to ovalbumin, Vibrio anguillarum and Freund's complete adjuvant
following intraperitoneal and bath immunisation. Fish and Shellfish
Immunology 4(7):475-488, ISSN:1050-4648.
Wiedermann, U., B. Jahn-Schmid, R. Fritsch, et al. (1998). Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: C
holrea toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen. Clinical and Experimental Immunology 111(1):144-151, ISSN:0009-9104.
Wilkie, B. (1990). Preparation of
antigen for immunization using L-Tyrosine or Di-Tyrosine adjuvants. In: Adjuvants:
Advances in Technology and Alternatives to Freund's (Conference Proceedings). The
Animal Resources Centre and the Faculty of Graduate Studies and Research, McGill
University: Montreal, Quebec. pp. 61. Woodard, L.F. (May 1989). Adjuvant
activity of water-insoluble surfactants. Laboratory Animal Science
39(3):222-225, ISSN:0023-6764. Wynne, C.R. (1974). The evaluation
of hydrocortisone antibodies produced in rabbits and sheep. I. Radioimmunoassay. Immunology
26(1):97-113, ISSN:0019-2805. Yokochi, T., Y. Inoue, et al. (1995). Strong
adjuvant action of Klebsiella O3 lipopolysaccharide and its inhibition of systemic
anaphylaxis. FEMS Immunology and Medical Microbiology 10(3-4): 181-184,
ISSN:0928-8244.
Zeidner, N.S. and D.L. Belasco (October
1995). Gliding bacterial adjuvant stimulates feline cytokines in vitro and
antigen-specific IgG in vivo. Vaccine 13(14):1294-1299, ISSN:0264-410X. |
[AWIC] |